Towards diagnostic criteria for the ANCA-associated vasculitidesLUQMANI, R. A.Clinical and experimental rheumatology (Testo stampato). 2007, Vol 25, Num 1, issn 0392-856X, p. S57, SUP44Conference Paper

British society for rheumatology and british health professionals in rheumatology guideline for the management of rheumatoid arthritis (the first two years)LUQMANI, R; HENNELL, S; MOHAMMED, R et al.Rheumatology (Oxford. Print). 2006, Vol 45, Num 9, pp 1167-1169, issn 1462-0324, 3 p.Article

The validity of surrogate markers in rheumatic diseaseEMERY, P; LUQMANI, R.British journal of rheumatology. 1993, Vol 32, pp 3-8, issn 0263-7103, SUP3Conference Paper

EULAR recommendations for the management of large vessel vasculitisMUKHTYAR, C; GUILLEVIN, L; MERKEL, P. A et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 3, pp 318-323, issn 0003-4967, 6 p.Article

Current state of tumour necrosis factor α blockade in Wegener's granulomatosisMUKHTYAR, C; LUQMANI, R.Annals of the rheumatic diseases. 2005, Vol 64, pp iv31-iv36, issn 0003-4967, SUP4Conference Paper

Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid diseaseLUQMANI, R; GORDON, C; BACON, P et al.Drugs (Basel). 1994, Vol 47, Num 2, pp 259-285, issn 0012-6667Article

Mortality in systemic vasculitis : a systematic reviewPHILLIP, R; LUQMANI, R.Clinical and experimental rheumatology (Testo stampato). 2008, Vol 26, Num 5, issn 0392-856X, S94-S104, SUP51Article

Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patientsARNOLD, D. F; TIMMS, A; LUQMANI, R et al.Journal of clinical pathology. 2010, Vol 63, Num 8, pp 678-680, issn 0021-9746, 3 p.Article

Necrotic granulomatous pseudotumours in bilateral resurfacing hip arthoplasties : evidence for a type IV immune responsePANDIT, H; VLYCHOU, M; WHITWELL, D et al.Virchows Archiv. 2008, Vol 453, Num 5, pp 529-534, issn 0945-6317, 6 p.Article

Disease-specific quality indicators, guidelines, and outcome measures in vasculitisMUKHTYAR, C; LUQMANI, R.Clinical and experimental rheumatology (Testo stampato). 2007, Vol 25, Num 6, issn 0392-856X, S120-S129, SUP47Article

Optimisation of cyclophosphamide therapy in systemic vasculitisRICHMOND, R; MCMILLAN, T. W; LUQMANI, R. A et al.Clinical pharmacokinetics. 1998, Vol 34, Num 1, pp 79-90, issn 0312-5963Article

Clinical and biological assessment in systemic necrotizing vasculitidesMUKHTYAR, C. B; FLOSSMANN, O; LUQMANI, R. A et al.Clinical and experimental rheumatology (Testo stampato). 2006, Vol 24, Num 2, issn 0392-856X, S92-S99, SUP41Article

Treat-to-target in vasculitis: is this a sensible approach?LUQMANI, R.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 4, issn 0392-856X, S149-S153, SUP73Article

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitisMUKHTYAR, C; HELLMICH, B; JAYNE, D et al.Clinical and experimental rheumatology (Testo stampato). 2006, Vol 24, Num 6, issn 0392-856X, S93-S99, SUP43Article

Medical student appraisal of interactive computer-assisted learning programs embedded in a general pathology courseREID, W. A; HARVEY, J; WATSON, G. R et al.Journal of pathology. 2000, Vol 191, Num 4, pp 462-465, issn 0022-3417Article

VITAL assessment of vasculitisBACON, P. A; MOOTS, R. J; EXLEY, A et al.Clinical and experimental rheumatology (Testo stampato). 1995, Vol 13, Num 2, pp 275-278, issn 0392-856XArticle

Two cases of wegener's tuberculosisGORDON, C; LUQMANI, R; FIELDS, P et al.British journal of rheumatology. 1993, Vol 32, Num 2, pp 143-149, issn 0263-7103Article

Inner ear deafnes in Wegener's granulomatosisLUQMANI, R; JUBB, R; EMERY, P et al.Journal of rheumatology. 1991, Vol 18, Num 5, pp 766-768, issn 0315-162X, 3 p.Article

Performance of the Birmingham Vasculitis Activity Score and Disease Extent Index in childhood vasculitidesDEMIRKAYA, E; OZEN, S; IAGARU, N et al.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 1, issn 0392-856X, S162-S168, SUP70Article

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitisMERKEL, P. A; CUTHBERTSON, D. D; SPECKS, U et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 1, pp 105-108, issn 0003-4967, 4 p.Article

EULAR recommendations for the management of primary small and medium vessel vasculitisMUKHTYAR, C; GUILLEVIN, L; MERKEL, P. A et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 3, pp 310-317, issn 0003-4967, 8 p.Article

Development of comprehensive disease assessment in systemic vasculitisFLOSSMANN, O; BACON, P; DE GROOT, K et al.Postgraduate medical journal. 2008, Vol 84, Num 989, pp 143-152, issn 0032-5473, 10 p.Article

An unusual cause of death in Wegener's granulomatosisSURESH, E; WONG, D; KAMALI, S et al.Annals of the rheumatic diseases. 2006, Vol 65, Num 5, pp 698-698, issn 0003-4967, 1 p.Article

Azathioprine, cyclophosphamide and chlorambucilLUQMANI, R. A; PALMER, R. G; BACON, P. A et al.Baillière's clinical rheumatology. 1990, Vol 4, Num 3, pp 595-619, issn 0950-3579, 25 p.Article

Nomenclature and classification of vasculitis ― update on the ACR/EULAR Diagnosis and Classification of Vasculitis Study (DCVAS)LUQMANI, R. A; SUPPIAH, R; GRAYSON, P. C et al.Clinical and experimental immunology (Print). 2011, Vol 164, pp 11-13, issn 0009-9104, 3 p., SUP1Conference Paper